These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 635321)

  • 1. Nomogram for prednisone-prednisolone adjustment dose in patients with hypoalbuminemia.
    Centeno F; Robles G; Uribe M; Lozada SG; Suárez GI
    Rev Invest Clin; 1978; 30(1):35-9. PubMed ID: 635321
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biotransformation of prednisone to prednisolone in patients with liver cirrhosis].
    Madsbad S; Bjerregaard B; Henriksen JH; Juhl E; Kehlet H
    Ugeskr Laeger; 1979 May; 141(20):1325-8. PubMed ID: 452141
    [No Abstract]   [Full Text] [Related]  

  • 3. Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects.
    Uribe M; Go VL; Kluge D
    J Clin Gastroenterol; 1984 Aug; 6(4):331-5. PubMed ID: 6481116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term therapy of chronic hepatitis].
    De Groote J; Maes H; Vandenbroucke J
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):15-7. PubMed ID: 5501420
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlled trial of low versus high dose oral steroid therapy in 100 cadaveric renal transplants.
    Buckels JA; Mackintosh P; Barnes AD
    Proc Eur Dial Transplant Assoc; 1981; 18():394-9. PubMed ID: 7036158
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum osteocalcin in the assessment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment.
    Peretz A; Praet JP; Bosson D; Rozenberg S; Bourdoux P
    J Rheumatol; 1989 Mar; 16(3):363-7. PubMed ID: 2786081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapy.
    Wagner JG; Wexler D; Ağabeyoğlu IT; Bergstrom RF; Sakmar E; Kay DR
    J Lab Clin Med; 1981 Apr; 97(4):487-501. PubMed ID: 7205057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum albumin metabolism in rheumatic diseases: relationship to corticosteroids and peptic ulcer.
    Niwa Y; Iio A; Niwa G; Sakane T; Tsunematsu T; Kanoh T
    J Clin Lab Immunol; 1990 Jan; 31(1):11-6. PubMed ID: 1966978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
    Mok CC; Ying KY; Mak A; To CH; Szeto ML
    Rheumatology (Oxford); 2006 Apr; 45(4):425-9. PubMed ID: 16234272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic hepatitis.
    Mistilis SP; Lam KC
    Prog Liver Dis; 1972; 4():419-32. PubMed ID: 4569006
    [No Abstract]   [Full Text] [Related]  

  • 11. [Steroid myopathy].
    Tsurutani H
    Kokyu To Junkan; 1990 Dec; 38(12):1211-6. PubMed ID: 2287816
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy.
    Shibasaki H; Nakayama H; Furuta T; Kasuya Y; Tsuchiya M; Soejima A; Yamada A; Nagasawa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):164-9. PubMed ID: 18387858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2008 Apr; 82(4):249-57. PubMed ID: 18414920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
    Schalm SW; Summerskill WH; Go VL
    Gastroenterology; 1977 May; 72(5 Pt 1):910-3. PubMed ID: 849821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of hypoalbuminemia in the critically ill patient.
    Marik PE
    Heart Lung; 1993; 22(2):166-70. PubMed ID: 8449761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis.
    Madsbad S; Bjerregaard B; Henriksen JH; Juhl E; Kehlet H
    Gut; 1980 Jan; 21(1):52-6. PubMed ID: 7364321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intermittent melphalan-predniso(lo)ne massive-dose therapy of plasmacytoma].
    Braun HJ
    Dtsch Med Wochenschr; 1972 Jan; 97(3):84-6. PubMed ID: 5007398
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical pharmacokinetics of prednisone and prednisolone.
    Pickup ME
    Clin Pharmacokinet; 1979; 4(2):111-28. PubMed ID: 378499
    [No Abstract]   [Full Text] [Related]  

  • 19. [Autoimmune hepatitis].
    Manns MP; Strassburg CP
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():39-42. PubMed ID: 12467006
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glucocorticoids and immunosuppressive agents in liver diseases].
    Arpa Gutierrez FJ; Silva Pozo J
    Rev Esp Enferm Apar Dig; 1970 Dec; 32(7):763-82. PubMed ID: 4926636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.